Hypoparathyroidism
MONDO:0001220Hypoparathyroidism is an endocrine disorder in which the parathyroid glands in the neck do not produce enough parathyroid hormone (PTH). Common signs and symptoms include abdominal pain, brittle nails, cataracts, dry hair and skin, muscle cramps, tetany, pain in the face, legs, and feet, seizures, tingling sensation, and weakened tooth enamel (in children). It may be caused by injury to the parathyroid glands (e.g., during surgery). Other causes, include low blood magnesium levels, a side effect of radioactive iodine treatment for hyperthyroidism, metabolic alkalosis, DiGeorge syndrome, and type I polyglandular autoimmune syndrome. The goal of treatment is to restore the calcium and mineral balance in the body.
Also known as: hypoparathyroidism, idiopathic (subtype), parathyroid, underactivity of
65 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could a cancer drug regrow hair in rare autoimmune disease?
Disease control Recruiting nowThis phase 2 trial tests whether ruxolitinib, a drug already approved for certain blood disorders, can help regrow hair in people with APECED, a rare immune condition that often causes severe alopecia areata. About 70 participants aged 12 to 75 will take the pill twice daily for …
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
MRNA therapy takes on hormone deficiency
Disease control Recruiting nowThis early-phase trial tests an mRNA drug called XH02 in 6 adults with hypoparathyroidism, a condition where the body lacks parathyroid hormone (PTH). The drug is designed to instruct cells to produce PTH after being given through a vein. The main goal is to check safety, while a…
Phase: EARLY_PHASE1 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
MRNA therapy offers hope for rare hormone disorder
Disease control Recruiting nowThis study tests an mRNA drug called XH-02 that helps the body produce parathyroid hormone (PTH) in adults with hypoparathyroidism, a condition where PTH levels are too low. The drug is given as a shot under the skin. The goal is to see if it safely improves calcium and phosphoru…
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can less calcium be just as good after thyroid removal?
Disease control Recruiting nowThis study looks at whether taking a lower dose of calcium (twice a day) works as well as a higher dose (four times a day) to prevent low calcium symptoms in the two weeks after thyroid surgery. About 50 adults who develop mild low calcium after surgery will be split into two gro…
Phase: NA • Sponsor: Tartu University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Higher dose hormone therapy aims to control rare calcium disorder
Disease control Recruiting nowThis phase 3 trial tests higher daily doses (over 30 mcg) of palopegteriparatide (Yorvipath) in 36 adults with chronic hypoparathyroidism. Participants already on the drug will have their dose adjusted to find the best level for controlling calcium without needing extra vitamin D…
Phase: PHASE3 • Sponsor: Ascendis Pharma Bone Diseases A/S • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New hope for kids with rare calcium disease: encaleret trial launches
Disease control Recruiting nowThis study tests a drug called encaleret in 28 children (birth to 17 years) with autosomal dominant hypocalcemia type 1 (ADH1), a rare genetic condition causing low blood calcium. The goal is to see if the drug can safely raise calcium levels and reduce urinary calcium loss. Part…
Phase: PHASE2, PHASE3 • Sponsor: Calcilytix Therapeutics, Inc., a BridgeBio company • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Arm injection during thyroid surgery could end lifelong calcium pills
Disease control Recruiting nowThis study tests a simple injection of mashed parathyroid tissue into the forearm during thyroid surgery. The goal is to prevent permanent low calcium levels that require lifelong medication. About 100 adults having thyroid surgery will receive this injection, and researchers wil…
Phase: NA • Sponsor: Medical University of Vienna • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
MRNA therapy takes on rare hormone disorder
Disease control Recruiting nowThis early-stage trial tests an mRNA drug called XH-02 in 15 adults with hypoparathyroidism, a condition where the body doesn't make enough parathyroid hormone. The drug is injected under the skin to help replace the missing hormone and control calcium levels. The main goal is to…
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Parathyroid transplant trial offers hope for rare hormone disorder
Disease control Recruiting nowThis early-phase study tests whether transplanting donated parathyroid tissue into the forearm can help people with hypoparathyroidism achieve normal calcium and phosphorus levels. The trial enrolls 3 adults who have low parathyroid hormone after surgery. Participants will receiv…
Phase: PHASE1, PHASE2 • Sponsor: Peter Stock • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New light probe aims to prevent thyroid surgery complication
Disease control Recruiting nowThis study tests a device called PTeye™ that uses near-infrared light to help surgeons see and protect tiny parathyroid glands during total thyroid removal. About 210 adults in Hong Kong will be randomly assigned to standard surgery or PTeye™-assisted surgery. The goal is to see …
Phase: NA • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for rare gut disease? drug trial launches for APECED enteritis
Disease control Recruiting nowThis phase 2 trial tests a drug called emapalumab in 10 people with APECED, a rare disease where the immune system attacks the body. The drug aims to reduce gut inflammation (enteritis) that causes severe symptoms. Participants receive 7 IV doses over 6 months, and researchers tr…
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Glow-in-the-dark tech may save parathyroid glands during thyroid cancer surgery
Disease control Recruiting nowThis study tests whether using a special camera (autofluorescence imaging) during thyroid cancer surgery can lower the risk of hypoparathyroidism, a condition where the parathyroid glands stop working properly. About 160 adults having their thyroid removed will be randomly assign…
Phase: NA • Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New calcium pill could ease burden for hypoparathyroidism patients
Disease control Recruiting nowThis study tests a new form of calcium called AMOR-1 in 81 adults with hypoparathyroidism, a condition where the body can't control calcium levels. Participants will take either AMOR-1 or standard calcium pills to see if AMOR-1 can better maintain normal calcium levels while allo…
Phase: PHASE2 • Sponsor: Amorphical Ltd. • Aim: Disease control
Last updated Jun 26, 2026 14:18 UTC
-
Glow-in-the-Dark probe could save parathyroid glands during thyroid surgery
Disease control Recruiting nowThis study tests whether a device called PTeye, which uses near-infrared light to make parathyroid glands glow, helps surgeons find and protect these tiny glands during thyroid surgery. The trial will compare outcomes in 154 patients who have their first total thyroidectomy, with…
Phase: NA • Sponsor: Marcin Barczynski • Aim: Disease control
Last updated Jun 26, 2026 12:41 UTC
-
Simple blood test may prevent thyroid surgery side effect
Prevention Recruiting nowThis study tests whether measuring parathyroid hormone (PTH) soon after thyroid removal can prevent symptomatic hypoparathyroidism, a condition causing low calcium and uncomfortable symptoms. About 336 adults having thyroid surgery will be monitored. If early PTH testing works, i…
Phase: NA • Sponsor: Nicolas Schlegel • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Green light during surgery may spare patients from lifetime of pills
Prevention Recruiting nowThis study tests whether using a special dye (indocyanine green) during total thyroidectomy helps surgeons see and protect the parathyroid glands, reducing the risk of permanent hypoparathyroidism. About 242 adults scheduled for total thyroid removal will be randomly assigned to …
Phase: PHASE3 • Sponsor: University Hospital, Brest • Aim: Prevention
Last updated Jun 27, 2026 11:03 UTC
-
10-Year study aims to predict dangerous calcium drop after thyroid removal
Knowledge-focused Recruiting nowThis study reviews 10 years of medical records from 600 adults who had thyroid surgery at Minia University Hospital. The goal is to find out which patients are most likely to develop low calcium levels after surgery, a common complication. By identifying key risk factors, doctors…
Sponsor: Minia University • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
NIH launches major study to unravel hormone mysteries
Knowledge-focused Recruiting nowThis study at the National Institutes of Health is looking at 1,000 adults with known or suspected hormone gland (endocrine) disorders. The goal is to better understand these conditions and help train doctors. Participants may receive tests, treatments, or surgery as part of thei…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Scientists seek clues to fungal infections in immune system study
Knowledge-focused Recruiting nowThis study aims to understand why some people are more prone to fungal infections, especially from Candida yeast. Researchers will collect blood, saliva, urine, and tissue samples from people with immune disorders, their family members, and healthy volunteers. No treatment is giv…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Massive study aims to unlock genetic secrets of childhood hormone disorders
Knowledge-focused Recruiting nowThis study enrolls up to 15,000 children with known or suspected endocrine or metabolic disorders, along with their family members. Researchers will collect medical records, blood, saliva, and other samples to identify genetic changes linked to these conditions. The goal is to be…
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Massive study aims to unlock secrets of parathyroid diseases
Knowledge-focused Recruiting nowThis study follows up to 3,000 people who have, are at risk for, or are related to someone with a parathyroid disorder. Researchers will collect medical records, questionnaires, and samples like blood and saliva to learn what causes these conditions and how they change over time.…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Scientists launch 25-Year quest to unravel mystery fungal infections
Knowledge-focused Recruiting nowThis study aims to understand why some people get severe or unusual fungal infections due to immune system problems. Researchers will collect blood, tissue, and other samples from up to 1,200 participants over 25 years. No new treatments are being tested; the goal is to learn mor…
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Thyroid surgery aftermath: can magnesium predict calcium crash?
Knowledge-focused Recruiting nowThis study follows 300 adults in Estonia who have their entire thyroid gland removed. The goal is to find out who is most likely to develop hypoparathyroidism—a condition where calcium levels drop after surgery—and whether low magnesium plays a role. Participants answer a questio…
Sponsor: Tartu University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Scientists launch major study to unravel hormone disorders
Knowledge-focused Recruiting nowThis study enrolls adults with known or suspected endocrine (hormone gland) disorders, such as diabetes or thyroid disease, to help researchers learn more about these conditions. Participants will undergo medical exams, blood and imaging tests, and possibly genetic testing. The m…
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
No treatment here: scientists Double-Check their own lab methods
Knowledge-focused Recruiting nowThis study is not testing a new drug or treatment. Instead, researchers want to make sure their lab tests and equipment give accurate and repeatable results when studying conditions like obesity, diabetes, heart disease, and bone loss. Up to 100 healthy volunteers and people with…
Sponsor: Bettina Mittendorfer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
New study checks if hypoparathyroidism drug passes into breast milk
Knowledge-focused Recruiting nowThis study looks at how much of the drug palopegteriparatide (YORVIPATH) gets into breast milk. It involves 10 women with hypoparathyroidism who are already taking the drug and breastfeeding. Researchers will collect milk samples to measure drug levels, helping understand safety …
Sponsor: Ascendis Pharma A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Can a simple questionnaire predict who will follow their treatment?
Knowledge-focused Recruiting nowThis study is testing a tool called B-COMPASS that uses a 22-question survey to predict whether people will follow their prescribed treatments. Researchers will enroll 3100 adults with cardiovascular, endocrine, immune, nerve, cancer, or rare diseases across Europe. The goal is t…
Phase: NA • Sponsor: Technical University of Madrid • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New registry aims to uncover risks of YORVIPATH during pregnancy
Knowledge-focused Recruiting nowThis registry study is collecting data from 50 women aged 15–50 who took YORVIPATH (palopegteriparatide) for hypoparathyroidism around the time of pregnancy or while breastfeeding. Researchers will monitor pregnancy complications, birth outcomes, and infant health through the fir…
Sponsor: Ascendis Pharma A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
2000-Patient study aims to uncover hidden metabolic risks in rare genetic disorders
Knowledge-focused Recruiting nowThis observational study will follow 2000 children and adults with imprinting disorders—rare genetic conditions like Silver-Russell and Prader-Willi syndromes. Researchers aim to describe the natural history of these diseases and identify common metabolic profiles, risks for obes…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
New study tracks Long-Term effects of rare hormone disorder
Knowledge-focused Recruiting nowThis study follows 106 adults with hypoparathyroidism for three years to see how the disease affects organs like the kidneys and brain. Researchers will measure kidney function and look for calcium buildup in the kidneys and brain using optional CT scans. The goal is to better un…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
New study aims to crack the code of autoimmune diseases
Knowledge-focused Recruiting nowThis study is collecting blood, urine, and stool samples from 500 children with autoimmune diseases and healthy controls. Researchers will analyze these samples to find molecular patterns that could help diagnose these conditions and guide treatment decisions. The goal is to crea…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:28 UTC